BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16280041)

  • 1. Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms.
    Pettigrew C; Wayte N; Lovelock PK; Tavtigian SV; Chenevix-Trench G; Spurdle AB; Brown MA
    Breast Cancer Res; 2005; 7(6):R929-39. PubMed ID: 16280041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variants.
    Pettigrew CA; Wayte N; Wronski A; Lovelock PK; Spurdle AB; Brown MA
    Breast Cancer Res Treat; 2008 Jul; 110(2):227-34. PubMed ID: 17899372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).
    Gorlov IP; Gorlova OY; Frazier ML; Amos CI
    Mutat Res; 2004 Oct; 554(1-2):175-83. PubMed ID: 15450416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unclassified variants identified in BRCA1 exon 11: Consequences on splicing.
    Anczuków O; Buisson M; Salles MJ; Triboulet S; Longy M; Lidereau R; Sinilnikova OM; Mazoyer S
    Genes Chromosomes Cancer; 2008 May; 47(5):418-26. PubMed ID: 18273839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition.
    Pavlicek A; Noskov VN; Kouprina N; Barrett JC; Jurka J; Larionov V
    Hum Mol Genet; 2004 Nov; 13(22):2737-51. PubMed ID: 15385441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.
    Campos B; Díez O; Domènech M; Baena M; Balmaña J; Sanz J; Ramírez A; Alonso C; Baiget M
    Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
    Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
    Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.
    Spurdle AB; Lakhani SR; Healey S; Parry S; Da Silva LM; Brinkworth R; Hopper JL; Brown MA; Babikyan D; Chenevix-Trench G; Tavtigian SV; Goldgar DE;
    J Clin Oncol; 2008 Apr; 26(10):1657-63. PubMed ID: 18375895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers.
    Smith PJ; Zhang C; Wang J; Chew SL; Zhang MQ; Krainer AR
    Hum Mol Genet; 2006 Aug; 15(16):2490-508. PubMed ID: 16825284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model.
    Yang Y; Swaminathan S; Martin BK; Sharan SK
    Hum Mol Genet; 2003 Sep; 12(17):2121-31. PubMed ID: 12915465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding.
    Millevoi S; Bernat S; Telly D; Fouque F; Gladieff L; Favre G; Vagner S; Toulas C
    Breast Cancer Res Treat; 2010 Apr; 120(2):391-9. PubMed ID: 19404736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression.
    Chen X; Truong TT; Weaver J; Bove BA; Cattie K; Armstrong BA; Daly MB; Godwin AK
    Hum Mutat; 2006 May; 27(5):427-35. PubMed ID: 16619214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of exonic splicing enhancer elements in human genes.
    Wu Y; Zhang Y; Zhang J
    Genomics; 2005 Sep; 86(3):329-36. PubMed ID: 16005179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-based analysis of BRCA1 and BRCA2 gene alterations.
    Bonatti F; Pepe C; Tancredi M; Lombardi G; Aretini P; Sensi E; Falaschi E; Cipollini G; Bevilacqua G; Caligo MA
    Cancer Genet Cytogenet; 2006 Oct; 170(2):93-101. PubMed ID: 17011978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BRCA1 c.5434C->G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements.
    Gaildrat P; Krieger S; Théry JC; Killian A; Rousselin A; Berthet P; Frébourg T; Hardouin A; Martins A; Tosi M
    J Med Genet; 2010 Jun; 47(6):398-403. PubMed ID: 20522429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive identification of exonic splicing enhancers in human genes.
    Fairbrother WG; Yeh RF; Sharp PA; Burge CB
    Science; 2002 Aug; 297(5583):1007-13. PubMed ID: 12114529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs.
    Vreeswijk MP; Kraan JN; van der Klift HM; Vink GR; Cornelisse CJ; Wijnen JT; Bakker E; van Asperen CJ; Devilee P
    Hum Mutat; 2009 Jan; 30(1):107-14. PubMed ID: 18693280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells.
    Lu M; Conzen SD; Cole CN; Arrick BA
    Cancer Res; 1996 Oct; 56(20):4578-81. PubMed ID: 8840964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of functional genetic polymorphism using ESE motif definition: a conservative evolutionary approach to CYP2D6/CYP2C19 gene variants.
    Samadi M; Beigi L; Yadegari F; Ansari AM; Majidzadeh-A K; Eskordi M; Farahmand L
    Genetica; 2022 Oct; 150(5):289-297. PubMed ID: 35913522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.